Proquad Merck & Co., Inc. - Treatment for Measles, Mumps, Rubella and Varicella Vaccination
Proquad is a combination of M-M-R II and Varivax in a single shot for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age.Posted: September 2005
Related articles
- Merck Files Biologics License Application for Proquad With U.S. Food and Drug Administration - November 4, 2004
ProQuad (measles, mumps, rubella and varicella virus vaccine, live) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
